175696-71-6

Usage

Uses

Used in Pharmaceutical Research:
(3-PIPERIDINOPHENYL)METHYLAMINE is used as a research compound for its potential role in the treatment of depression and other psychiatric disorders. It is studied for its effects on mood and cognitive function, aiming to understand its potential therapeutic benefits and mechanisms of action.
Used in Neurological Research:
In the field of neurology, (3-PIPERIDINOPHENYL)METHYLAMINE is used as a research compound for its potential application in the treatment of Parkinson's disease. It is investigated for its ability to modulate neurotransmitter systems and improve motor function, which could be beneficial for patients suffering from this condition.
Used in Receptor Studies:
(3-PIPERIDINOPHENYL)METHYLAMINE is used as a ligand in the study of various receptors, allowing researchers to explore its interactions with these biological targets. This can provide insights into the compound's pharmacological profile and potential applications in drug development.

InChI:InChI=1/C12H18N2/c13-10-11-5-4-6-12(9-11)14-7-2-1-3-8-14/h4-6,9H,1-3,7-8,10,13H2

Upstream product

• 403-54-3 m-Fluorobenzonitrile 
• 110-89-4 piperidine 
• 2237-30-1 m-cyanoaniline 
• 111-24-0 1,5-dibromo-pentane 
• 175696-74-9 3-(piperidin-1-yl)benzonitrile 

Relevant academic research and scientific papers

A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters

With the ever-increasing instances of resistance to frontline TB drugs there is the need to develop novel strategies to fight the worldwide TB epidemic. Boosting the effect of the existing second-line antibiotic ethionamide by inhibiting the mycobacterial

PYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF PKC-THETA

Disclosed are novel compounds of formula (I) wherein R1, R2, R3 , R4 and A are as defined herein, which are useful as inhibitors of PKC-theta and are thus useful for treating a variety of diseases and disorders

Pyrimidine derivatives useful as inhibitors of PKC-theta

Disclosed are novel compounds of formula (I): wherein X, Y, R1, R2 and R3 are as defined herein, which are useful as inhibitors of PKC-theta and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC-theta, including immunological disorders and type II diabetes. This invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

The antiinfluenza activity of pyrrolo[2,3-d]pyrimidines

From a group of pyrrolo[2,3-d]pyrimidine compounds that have been screened against influenza virus, one derivative, 4-(3-piperidinyl benzylamino)-2-methyl-7H-pyrrolo[2,3-d]pyrimidine (9), has shown promising activity against both the A and B strains. The